Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 892.00
-1.00 (-0.11%)
At close: Jun 3, 2025
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 137.91 billion as of June 3, 2025. Its market cap has increased by 160.32% in one year.
Market Cap
137.91B
Enterprise Value
128.37B
Revenue
40.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
892.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 137.91B, an increase of 1,632.90%. That is a compound annual growth rate of 222.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 137.91B | 46.15% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 171.35B |
| Bora Pharmaceuticals Co., LTD. | 84.84B |
| Lotus Pharmaceutical | 61.87B |
| Polaris Group | 29.89B |
| Center Laboratories | 28.67B |
| Lumosa Therapeutics | 27.43B |
| Oneness Biotech | 27.07B |
| Pegavision | 25.86B |